James Tollitt

503 total citations
20 papers, 177 citations indexed

About

James Tollitt is a scholar working on Nephrology, Epidemiology and Molecular Biology. According to data from OpenAlex, James Tollitt has authored 20 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in James Tollitt's work include Dialysis and Renal Disease Management (5 papers), Dementia and Cognitive Impairment Research (3 papers) and Acute Kidney Injury Research (3 papers). James Tollitt is often cited by papers focused on Dialysis and Renal Disease Management (5 papers), Dementia and Cognitive Impairment Research (3 papers) and Acute Kidney Injury Research (3 papers). James Tollitt collaborates with scholars based in United Kingdom, Hong Kong and Italy. James Tollitt's co-authors include Nikki A. Copeland, Philip A. Kalra, Dimitrios Poulikakos, Aghogho Odudu, John J. Worthington, Sheila McCorkindale, Emma Flanagan, Smeeta Sinha, Daniela Montaldi and Rajkumar Chinnadurai and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

James Tollitt

20 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Tollitt United Kingdom 7 54 48 46 36 26 20 177
Caroline Roubiou France 8 38 0.7× 25 0.5× 89 1.9× 19 0.5× 11 0.4× 14 226
Yingrong Du China 7 7 0.1× 31 0.6× 43 0.9× 47 1.3× 16 0.6× 30 190
Kaoutar Jidar France 5 18 0.3× 22 0.5× 54 1.2× 48 1.3× 3 0.1× 9 202
Maxime Espi France 5 39 0.7× 16 0.3× 20 0.4× 91 2.5× 36 1.4× 9 218
Ravi Nayak United States 10 9 0.2× 33 0.7× 24 0.5× 12 0.3× 112 4.3× 24 211
Gábor Telkes Hungary 9 23 0.4× 43 0.9× 74 1.6× 8 0.2× 65 2.5× 19 292
Zeynep Yürük Yıldırım Türkiye 7 58 1.1× 29 0.6× 18 0.4× 15 0.4× 12 0.5× 30 160
Annika Belzer United States 8 10 0.2× 33 0.7× 48 1.0× 15 0.4× 33 1.3× 25 162
Ronaldo de Matos Esmeraldo Brazil 7 16 0.3× 60 1.3× 32 0.7× 54 1.5× 18 0.7× 20 226
Hassan Tarhini France 5 35 0.6× 21 0.4× 20 0.4× 132 3.7× 12 0.5× 8 188

Countries citing papers authored by James Tollitt

Since Specialization
Citations

This map shows the geographic impact of James Tollitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Tollitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Tollitt more than expected).

Fields of papers citing papers by James Tollitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Tollitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Tollitt. The network helps show where James Tollitt may publish in the future.

Co-authorship network of co-authors of James Tollitt

This figure shows the co-authorship network connecting the top 25 collaborators of James Tollitt. A scholar is included among the top collaborators of James Tollitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Tollitt. James Tollitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tollitt, James, et al.. (2025). Pathophysiology of cognitive impairment in chronic kidney disease. Current Opinion in Nephrology & Hypertension. 34(6). 459–468. 1 indexed citations
2.
Chinnadurai, Rajkumar, et al.. (2024). Health outcomes in chronic kidney disease patients with cognitive impairment or dementia: a global collaborative analysis. Clinical Kidney Journal. 18(1). sfae401–sfae401. 4 indexed citations
3.
Tollitt, James, Nikolaos Marketos, Ajay Dhaygude, et al.. (2024). IgA vasculitis nephritis—outcomes in adult-onset disease. Lara D. Veeken. 64(2). 690–696. 4 indexed citations
4.
Tollitt, James, Stuart M. Allan, Rajkumar Chinnadurai, et al.. (2022). Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?. BMC Nephrology. 23(1). 38–38. 2 indexed citations
5.
Tollitt, James, et al.. (2022). Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway. Biomedicines. 10(8). 2012–2012. 1 indexed citations
6.
Park, J., Fatai S. Oladunni, James Tollitt, et al.. (2021). Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2. iScience. 24(9). 102941–102941. 36 indexed citations
7.
Tollitt, James, Aghogho Odudu, Daniela Montaldi, & Philip A. Kalra. (2020). Cognitive impairment in patients with moderate to severe chronic kidney disease: the Salford kidney cohort study. Clinical Kidney Journal. 14(6). 1639–1648. 15 indexed citations
8.
Tollitt, James, et al.. (2020). Helminth Sensing at the Intestinal Epithelial Barrier—A Taste of Things to Come. Frontiers in Immunology. 11. 1489–1489. 11 indexed citations
9.
Tollitt, James, et al.. (2020). Identification of DHX9 as a cell cycle regulated nucleolar recruitment factor for CIZ1. Scientific Reports. 10(1). 18103–18103. 6 indexed citations
10.
Tollitt, James, Emma Flanagan, Paul Chadwick, et al.. (2019). The importance of acute kidney injury in suspected community acquired infection. PLoS ONE. 14(5). e0216412–e0216412. 4 indexed citations
11.
Tollitt, James, Aghogho Odudu, Emma Flanagan, et al.. (2019). Impact of prior stroke on major clinical outcome in chronic kidney disease: the Salford kidney cohort study. BMC Nephrology. 20(1). 432–432. 13 indexed citations
12.
Tollitt, James, Emma Flanagan, Sheila McCorkindale, et al.. (2018). Improved management of acute kidney injury in primary care using e-alerts and an educational outreach programme. Family Practice. 35(6). 684–689. 10 indexed citations
13.
Tollitt, James, Aghogho Odudu, Daniela Montaldi, & Philip A. Kalra. (2018). Cognitive impairment in chronic kidney disease and dialysis. Research Explorer (The University of Manchester). 3(1). 23–29. 1 indexed citations
14.
Tollitt, James, et al.. (2017). The Evidence of Acute Kidney Injury in the Community and for Primary Care Interventions. ˜The œNephron journals/Nephron journals. 136(3). 202–210. 14 indexed citations
15.
Tollitt, James, Emma Flanagan, Sheila McCorkindale, et al.. (2017). SO042A COLLABORATIVE QUALITY IMPROVEMENT PROJECT TO IMPROVE MANAGEMENT OF COMMUNITY ACQUIRED PRIMARY CARE AKI (CAPAKI) USING E ALERTS AND AN EDUCATIONAL OUTREACH PROGRAMME. Nephrology Dialysis Transplantation. 32(suppl_3). iii25–iii26. 1 indexed citations
16.
Tollitt, James, Edmond O’Riordan, & Dimitrios Poulikakos. (2016). CMV disease complicating induction immunosuppressive treatment for ANCA-associated vasculitis. BMJ Case Reports. 2016. bcr2015214018–bcr2015214018. 4 indexed citations
17.
Tollitt, James, et al.. (2016). Emerging Roles for Ciz1 in Cell Cycle Regulation and as a Driver of Tumorigenesis. Biomolecules. 7(1). 1–1. 40 indexed citations
18.
Tollitt, James & L. R. Solomon. (2014). Hypercalcaemia and acute kidney injury following administration of vitamin D in granulomatous disease. BMJ Case Reports. 2014. bcr2014203824–bcr2014203824. 5 indexed citations
19.
Tollitt, James, Alan J. Duncan, & Alexander Woywodt. (2013). Of mites and men: scabies in patients with kidney disease. Clinical Kidney Journal. 6(2). 125–127. 2 indexed citations
20.
Tollitt, James, Ajay K. Jain, & Sue Astley. (2008). Health inequalities in breast cancer screening. Breast Cancer Research. 10(S2). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Roubiou Breakdown of academic impact, for papers by Yingrong Du Breakdown of academic impact, for papers by Kaoutar Jidar Breakdown of academic impact, for papers by Maxime Espi Breakdown of academic impact, for papers by Ravi Nayak Breakdown of academic impact, for papers by Gábor Telkes Breakdown of academic impact, for papers by Zeynep Yürük Yıldırım Breakdown of academic impact, for papers by Annika Belzer Breakdown of academic impact, for papers by Ronaldo de Matos Esmeraldo Breakdown of academic impact, for papers by Hassan Tarhini
Rankless by CCL
2026